NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Prescription·Evidence index

Alcohol and Baclofen: what the published research says

PubMed indexes 8 records that name Alcohol and Baclofen together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Alcohol and Baclofen. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

8 studies naming Alcohol and Baclofen.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

Baclofen for alcohol use disorder-a systematic meta-analysis.

Acta psychiatrica Scandinavica · 2018 · PMID 29888478

Comparative StudyMeta-AnalysisSystematic ReviewHuman subjects

“Our results question baclofen's utility in the long-term treatment of alcohol use disorder at both normal and high doses. While the confidence intervals indicate that marginally harmful or moderately beneficial effects of baclofen remain a possibility, the most likely effect size is slightly above placebo effects.”

Bschor et al. · Authors' conclusion

Names both Alcohol and Baclofen in its title.

Baclofen for alcohol use disorder.

The Cochrane database of systematic reviews · 2023 · PMID 36637087

Systematic ReviewHuman subjects

“Baclofen likely reduces the risk of relapse to any drinking and increases the percentage of abstinent days, mainly among detoxified participants. It does not increase the number of participants with at least one adverse event, those who dropout for any reason or due to adverse events. It probably does not reduce number of heavy drinking days and the number of drinks per drinking days. Current evidence suggests that baclofen may help people with AUD in maintaining abstinence.”

Agabio et al. · Authors' conclusion

Names both Alcohol and Baclofen in its title.

Baclofen for alcohol withdrawal.

The Cochrane database of systematic reviews · 2019 · PMID 31689723

Meta-AnalysisSystematic ReviewHuman subjects

“No conclusions can be drawn about the efficacy and safety of baclofen for the management of alcohol withdrawal because we found insufficient and very low-quality evidence.”

Liu et al. · Authors' conclusion

Names both Alcohol and Baclofen in its title.

The efficacy of baclofen in alcohol dependence

Tijdschrift voor psychiatrie · 2019 · PMID 31512738

Meta-AnalysisSystematic ReviewHuman subjects

“The other meta-analysis did not show an effect on the primary outcome measures. AIM: To clarify the clinical relevance of the effect of baclofen on alcohol use in patients with a disorder in the use of alcohol, in the light of the positive and the negative meta-analysis. METHOD: A systematic literature search using Medline, Embase and PsycINFO (Prisma guideline). RESULTS: We found 16 randomized controlled trials in which the effect of baclofen was studied.”

Neven et al. · From the abstract

Names both Alcohol and Baclofen in its title.

Baclofen for alcohol use disorder.

The Cochrane database of systematic reviews · 2018 · PMID 30484285

Meta-AnalysisSystematic ReviewHuman subjects

“None of the primary or secondary outcomes of the review showed evidence of a difference between baclofen and placebo. The high heterogeneity among primary studies results limits the interpretation of the summary estimate, the identification of moderators and mediators of baclofen's effects on alcohol use remains a challenge for further research.”

Minozzi et al. · Authors' conclusion

Names both Alcohol and Baclofen in its title.

Baclofen for alcohol withdrawal.

The Cochrane database of systematic reviews · 2017 · PMID 28822350

Systematic ReviewHuman subjects

“No conclusions can be drawn about the efficacy and safety of baclofen for the management of alcohol withdrawal because we found insufficient and very low quality evidence.”

Liu et al. · Authors' conclusion

Names both Alcohol and Baclofen in its title.

Baclofen for alcohol withdrawal.

The Cochrane database of systematic reviews · 2015 · PMID 25836263

Systematic ReviewHuman subjects81 participants

“The evidence for recommending baclofen for AWS is insufficient. We therefore need more well-designed RCTs to prove its efficacy and safety.”

Liu et al. · Authors' conclusion

Names both Alcohol and Baclofen in its title.

Baclofen for alcohol withdrawal.

The Cochrane database of systematic reviews · 2013 · PMID 23450582

Systematic ReviewHuman subjects

“The evidence for recommending baclofen for AWS is insufficient. More well designed RCTs are needed to prove its efficacy and safety.”

Liu et al. · Authors' conclusion

Names both Alcohol and Baclofen in its title.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Alcohol, Baclofen, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.